Taken together, these results further validate the fact that the activation of the ERK1/2 signaling pathway affects the functional outcome of TMPRSS4, that is, promotes cell proliferation and inhibits apoptosis in pancreatic cancer. Here, MAPK3 is linked to familial pancreatic carcinoma.